- Category
- Small (2023-24)
- Udyam number
- UDYAM-UK-05-0027578

Parb Bioceuticals Private Limited
About Parb Bioceuticals Private Limited
Data last updated:
Parb Bioceuticals Private Limited is a private limited company based in Sirmaur, Himachal Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 11 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24230HP2021PTC008554.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Parshotam Lal Goyal and Konic Goyal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Village Ogli Nahan Road Kala Amb, Sirmaur, Himachal Pradesh, India – 173030.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.98 Cr, a decline of 91% compared to the previous year. For the same year it recorded a net profit of ₹30.85 Lakh (net margin 6.2%) and EBITDA of ₹42.08 Lakh (EBITDA margin 8.4%). Revenue has declined at a compounded annual rate (CAGR) of 32% over three years.
Parb Bioceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-05-0027578).
Company details
Recognitions & Rankings of Parb Bioceuticals
Contact details
Parb Bioceuticals Private Limited's registered office is in Sirmaur, Himachal Pradesh.
- Registered AddressVillage Ogli Nahan Road Kala Amb, Sirmaur, Himachal Pradesh, India – 173030
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Parb Bioceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Parb Bioceuticals Private Limited, buy the company report.
Financials of Parb Bioceuticals Private Limited
FY 2025 filings availableParb Bioceuticals Private Limited reported revenue of ₹4.98 Cr (down 91% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 32% over three years, including a 91% fall in the latest year. EBITDA fell 94% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹42.08 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹30.85 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 8.4% | |||
| Net Profit Margin | 6.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Parb Bioceuticals Private Limited, buy the company report.
Board of directors of Parb Bioceuticals Private Limited
Parb Bioceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anuj Kumar Also directs: Parb Pharmaceuticals Private Limited | Additional Director | 20 May 2022 | 4 Years 5 Months | Current |
| Parshotam Lal Goyal | Director | 11 May 2021 | 5 Years 5 Months | Current |
| Konic Goyal | Director | 11 May 2021 | 5 Years 5 Months | Current |
Peer comparison
Parb Bioceuticals Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Xython Biotech Private Limited | ₹4.99 Cr (FY 2025) | 50.0% | Bangalore, Karnataka, India | |||
| Jagore Life Sciences Private Limited | ₹4.99 Cr (FY 2025) | 60.0% | Sanga Reddy, Telangana, India | |||
| Jei Health Care Private Limited | ₹4.99 Cr (FY 2024) | 1013.0% | Coimbatore, Tamil Nadu, India | |||
| Gufic Stridden Bio-Pharma Private Limited | ₹4.98 Cr (FY 2017) | -14.0% | Mumbai, Maharashtra, India | |||
| Medinex Speciality Chemicals Private Limited | ₹4.98 Cr (FY 2025) | 32.0% | Bhavnagar, Gujarat, India | |||
| Parb Bioceuticals Private Limitedthis company | ₹4.98 Cr (FY 2025) | ₹30.85 Lakh | 6.2% | -91.0% | Sirmaur, Himachal Pradesh, India | |
| Chemlinker Tradex Private Limited | ₹4.98 Cr (FY 2019) | -45.0% | New Delhi, Delhi, India | |||
| Siyaz Life Sciences Private Limited | ₹4.97 Cr (FY 2025) | 0.0% | Chandigarh, India | |||
| H Cube Hygiene Products Private Limited | ₹4.96 Cr (FY 2024) | -81.0% | Rajkot, Gujarat, India | |||
| Sidhdeep Biotech Private Limited | ₹4.96 Cr (FY 2025) | 22.0% | Hapur, Uttar Pradesh, India | |||
| LVK Pharma Private Limited | ₹4.95 Cr (FY 2025) | 245.0% | Secunderabad, Telangana, India |
To see the full peer comparison of Parb Bioceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Parb Bioceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Parb Bioceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Parb Bioceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Parb Bioceuticals Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Anuj Kumar was appointed as Additional Director on 20 May 2022.
Frequently asked questions
Parb Bioceuticals is an active private limited company based in Sirmaur, Himachal Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 11 May 2021 (5+ years old) and is registered under CIN U24230HP2021PTC008554.
Parb Bioceuticals has 3 current directors:
- Anuj Kumar - Additional Director
- Parshotam Lal Goyal - Director
- Konic Goyal - Director
The latest financial statements of Parb Bioceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Parb Bioceuticals is U24230HP2021PTC008554. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Parb Bioceuticals was incorporated on 11 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of Parb Bioceuticals by revenue are Xython Biotech Private Limited, Jagore Life Sciences Private Limited, Jei Health Care Private Limited, Gufic Stridden Bio-Pharma Private Limited, Medinex Speciality Chemicals Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anuj Kumar was appointed as Additional Director on 20 May 2022. Konic Goyal was appointed as Director on 11 May 2021. Parshotam Lal Goyal was appointed as Director on 11 May 2021.
Yes, Parb Bioceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-UK-05-0027578).
The registered office of Parb Bioceuticals is at Village Ogli Nahan Road Kala Amb, Sirmaur, Himachal Pradesh, India – 173030.
Parb Bioceuticals operates in the chemicals industry, in the manufacturing segment.
Parb Bioceuticals can be reached at its registered office: Village Ogli Nahan Road Kala Amb, Sirmaur, Himachal Pradesh, India – 173030.